IT1188557B - Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici - Google Patents

Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici

Info

Publication number
IT1188557B
IT1188557B IT19594/86A IT1959486A IT1188557B IT 1188557 B IT1188557 B IT 1188557B IT 19594/86 A IT19594/86 A IT 19594/86A IT 1959486 A IT1959486 A IT 1959486A IT 1188557 B IT1188557 B IT 1188557B
Authority
IT
Italy
Prior art keywords
bone
azabicycle
octane
carboxylic
acids
Prior art date
Application number
IT19594/86A
Other languages
English (en)
Other versions
IT8619594A1 (it
IT8619594A0 (it
Inventor
David R Kronenthal
Paula L Kuester
William H Koster
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IT8619594A0 publication Critical patent/IT8619594A0/it
Publication of IT8619594A1 publication Critical patent/IT8619594A1/it
Application granted granted Critical
Publication of IT1188557B publication Critical patent/IT1188557B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT19594/86A 1985-03-01 1986-02-28 Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici IT1188557B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/707,357 US4574153A (en) 1985-03-01 1985-03-01 8-Oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxylic acids

Publications (3)

Publication Number Publication Date
IT8619594A0 IT8619594A0 (it) 1986-02-28
IT8619594A1 IT8619594A1 (it) 1987-08-28
IT1188557B true IT1188557B (it) 1988-01-20

Family

ID=24841378

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19594/86A IT1188557B (it) 1985-03-01 1986-02-28 Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici

Country Status (6)

Country Link
US (1) US4574153A (it)
JP (1) JPS61212588A (it)
DE (1) DE3606584A1 (it)
FR (1) FR2578255B1 (it)
GB (1) GB2171701B (it)
IT (1) IT1188557B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008404A (en) * 1988-08-01 1991-04-16 Schering Corporation Preparation of azetidinones via novel protected intermediates
US5089609A (en) * 1986-03-13 1992-02-18 Schering Corporation 4-benzoyl azetidinones
US4827006A (en) * 1986-03-13 1989-05-02 Schering Corporation Preparation of azetidinones via novel protected intermediates
US8263579B2 (en) * 2011-01-24 2012-09-11 Piramal Healthcare Limited Anti-inflammatory compounds
IN2014MN00174A (it) * 2011-06-30 2015-06-19 Godavari Biorefineries Ltd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458071A (en) * 1982-11-16 1984-07-03 Eli Lilly And Company Process for 1-oxa-β-lactams

Also Published As

Publication number Publication date
IT8619594A1 (it) 1987-08-28
FR2578255B1 (fr) 1989-01-06
GB8604686D0 (en) 1986-04-03
JPS61212588A (ja) 1986-09-20
FR2578255A1 (fr) 1986-09-05
GB2171701B (en) 1988-10-12
GB2171701A (en) 1986-09-03
IT8619594A0 (it) 1986-02-28
US4574153A (en) 1986-03-04
DE3606584A1 (de) 1986-09-04

Similar Documents

Publication Publication Date Title
DE3854495D1 (de) Tetrapyrrolaminocarbonsäuren.
DE3686172D1 (de) Peptid-derivate.
FI862434A7 (fi) Foerfarande foer framstaellning av difluor-ketonpeptidderivat.
DK565987D0 (da) Substituerede aminosyrer
DE3685167D1 (de) Calcitoningen-verwandte peptidderivate.
IT8720786A0 (it) Acidi bifenil-idrossamici.
ES543630A0 (es) Acidos 1-ciclopropilquinolon-3-carboxilicos
FI863558A7 (fi) 3-amino-dihydro(1)-bensopyraner och -bensotiopyraner.
FI863597L (fi) Foerfarande foer framstaellning av tetrafluorbensoesyra.
DK131087D0 (da) 1,2,3,4-tetrahydro-6-substitueret-4-aryl-(eller -heterocyclo-)-3-substitueret-2-thioxo-/eller -oxo)-5-pyrimidincarboxylsyrer og estere
ATE90079T1 (de) Substituierte 2-phenyl-4-chinolincarbonsaeuren.
NO862970L (no) 3-propenylcephalosporinsolvater.
DE3766436D1 (de) Hydroxyphosphono-carbonsaeuren.
NO164392C (no) Fremgangsmaate for forbedring av hydrolysert protein.
NL8601645A (nl) 3-(gesubstitueerde)propenylaminothiazolyl-cefalosporanzuren en esters daarvan.
IT1190130B (it) Acidi 3-acilammino-2-osso-1-azetidinsolfonici
FI854730A0 (fi) Vattentorn 2000.
IT1188557B (it) Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici
FI861947A7 (fi) Hekseenihappoja.
DE3676594D1 (de) Cyclohexanalkansaeuren.
FI865302A7 (fi) Dioksaanihekseenihappoja.
DE3675838D1 (de) 5-chloro-s-triazolo(4,3-a)pyridin-7-carbonsaeuren.
NO863044D0 (no) Fremgangsmaate for fremstilling av 5,6-dialkoksyantranilsyrer.
FI864790A7 (fi) 5-kloori- ja 5-bromi-2 -hydroksinikotiinihappojen valmistusmenetelmä.
DK161888D0 (da) Trioxabicyclo (2.2.2) octanderivater